This article reports data pertaining to a worldwide web-based survey referenced in the publication "Adult CSF Total Protein: Higher upper reference limits should be considered worldwide " (P.R. . This survey was distributed to corresponding authors of the journal Neurology and the Journal of neurological sciences for the period of JaneDec 2017. The response rate was 36.9%. Additional results were collated through networking and national associations. There were 473 unique responses from clinical hospital laboratories in 69 countries: North America 178, South America 26, Europe 139, Africa 20, Asia 102 and Oceania 8. The upper reference limit for cerebrospinal fluid total protein ranged from 0.2 g/L to 0.8 g/L. 86.8% of the survey responses were 0.45 g/L or less. Data is presented separately for tertiary/academic and non-university/community centers.
Data
A flow chart of the survey response acquisition process and exclusion of duplicate answers is presented in Fig. 1 . Upper reference limit results for CSF total protein are presented in histograms, separated by type of clinical hospital laboratory (Fig. 2) . A table provides data on the number of responses, institutional type, and CSF-TP range, divided by continent and country. Geolocation maps document the worldwide distribution of clinical hospital laboratories surveyed (Figs. 3AeE).
Experimental design, materials, and methods
This survey was approved by the Ethics board of the Ottawa Hospital Research Institute. To obtain a distribution list, we first generated a list of 759 clinical neuroscientists from the "corresponding author" designations in the following two clinical neurology journals, chosen for their worldwide catchment: Neurology (410 email addresses) and the Journal of Neurological Sciences (339 email addresses). Both journals were surveyed for the period of JaneDec 2017. Additional responses were obtained by distribution to a listserv approved by the relevant authority (Canadian Neurological Sciences Federation, Russian Federation of Laboratory Medicine). Finally, individual worldwide responses were added through direct networking with clinical neurology and laboratory medicine peers. When several responses were obtained from the same center, the highest stated value was entered for data analysis. As the data does not approximate a normal distribution, median CSF total protein values are reported for the academic centers and community institutions. Table 1 .
The survey consisted of the following 3 main questions: 1) What is the CSF TP upper reference value at your institution for adult patients? (e.g. < 0.45 g/L/ < 0.60 g/L/or specify any different value); 2) Do you use age-adjusted reference limits for adults (e.g. < 50 years, > 50 years of age) ? (yes/no); 3) What is the source of your CSF TP reference intervals? (Published laboratory references/Institution specific reference values, derived from local data/Unknown).
Value of the data
The data documents which CSF total protein reference values are currently used in 69 countries worldwide. 
